Ignite Creation Date:
2025-12-24 @ 10:36 PM
Ignite Modification Date:
2025-12-28 @ 5:20 AM
Study NCT ID:
NCT05432635
Status:
RECRUITING
Last Update Posted:
2025-02-18
First Post:
2022-06-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma
Sponsor:
City of Hope Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-01
Start Date Type:
ACTUAL
Primary Completion Date:
2028-03-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-21
First Submit QC Date:
None
Study First Post Date:
2022-06-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-17
Last Update Post Date:
2025-02-18
Last Update Post Date Type:
ACTUAL